Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis.
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
American Medical Association fact sheet on ocrelizumab
Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset.
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Myelin Sheath Development in the Maxillary Nerve of the Newborn Pig.
CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.
Leptin and other adipokines in EAE and MS
Sodium intake is associated with increased disease activity in multiple sclerosis.
Systematic Review of the Economics of Multiple Sclerosis in Latin America.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
The Characteristics of Multiple Sclerosis in Iran.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.